Man Group
AUPH icon

Man Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Man Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
83,888
-867,524
-91% -$13.9M ﹤0.01% 1727
2026
Q1 		$14.1M Buy
951,412
+98,741
+12% +$1.44M 0.03% 659
2025
Q4 		$13.6M Buy
852,671
+670,812
+369% +$9.51M 0.02% 660
2025
Q3 		$2.01M Buy
181,859
+154,567
+566% +$1.69M ﹤0.01% 1418
2025
Q2 		$231K Buy
+27,292
New +$219K ﹤0.01% 2032
2025
Q1 		– Sell
-19,742
Closed -$177K – 2171
2024
Q4 		$177K Sell
19,742
-79,629
-80% -$650K ﹤0.01% 1883
2024
Q3 		$728K Buy
+99,371
New +$616K ﹤0.01% 1572
2021
Q3 		– Sell
-28,983
Closed -$376K – 1893
2021
Q2 		$376K Sell
28,983
-81,572
-74% -$1.04M ﹤0.01% 1633
2021
Q1 		$1.44M Sell
110,555
-202,628
-65% -$2.94M 0.01% 1205
2020
Q4 		$4.33M Sell
313,183
-8,070
-3% -$117K 0.02% 892
2020
Q3 		$4.73M Buy
321,253
+5,922
+2% +$85.8K 0.02% 837
2020
Q2 		$5.12M Buy
315,331
+231,743
+277% +$3.71M 0.03% 648
2020
Q1 		$1.21M Buy
+83,588
New +$1.47M 0.01% 1060
2019
Q1 		– Sell
-20,900
Closed -$143K – 1950
2018
Q4 		$143K Sell
20,900
-36,800
-64% -$212K ﹤0.01% 1831
2018
Q3 		$383K Sell
57,700
-800
-1% -$4.49K ﹤0.01% 1896
2018
Q2 		$329K Buy
58,500
+25,700
+78% +$143K ﹤0.01% 1901
2018
Q1 		$170K Buy
+32,800
New +$175K ﹤0.01% 1935

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's AUPH Position: Q2 2026 in Review

Man Group reduced its Aurinia Pharmaceuticals (AUPH) stake by 91% in Q2 2026, selling an estimated $13.9M and leaving 83,888 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

Man Group first reported a position in AUPH in Q1 2018 and has held it in 17 quarters since. The position peaked at $14.1M in Q1 2026. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Man Group held 83,888 shares of Aurinia Pharmaceuticals worth $1.42M as of Q2 2026.
  • Man Group sold 867,524 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $13.9M.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1727 holding.
  • Man Group first reported a position in Aurinia Pharmaceuticals in Q1 2018 and has held it in 17 quarters since.
  • Man Group's Aurinia Pharmaceuticals position peaked at $14.1M in Q1 2026.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.